Faculty

Institution

Unit

Venue

Michael S O'Reilly, MD

Professor Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Thoracic Radiation Oncology

Department Of Thoracic Surgery

Department Of Thoracic-Head And Neck Med Onc

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

Michael S O'reilly, Md is currently serving as a Breast Radiation Oncology Professor Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael S O'Reilly, MD

The University of Texas MD Anderson Cancer Center

Professor Associate Professor

You can click a keyword to filter the displayed items

radiation oncology oncology lung cancer thoracic oncology cancer research cancer treatment radiation therapy cancer care clinical radiation oncology pharmacology medicine medicinal research radiation radiology cancer biology tumor biology clinical research tumor targeting therapeutic targets vascular biology surgical oncology cellular therapy radiation biology cancer imaging cancer management cancer genomics cancer cells respiratory medicine molecular cancer anti-cancer agents pharmacotherapy nuclear medicine proton therapy clinical trials oncogenes angiogenesis enzyme inhibition esophageal cancer drug targeting cancer genetics bronchial neoplasm receptor tyrosine kinases radiopharmaceutical therapy clinical investigation pancreatic cancer stereotactic ablative radiotherapy concurrent chemotherapy phase ii trial experimental medicine radiation therapy planning therapeutic efficacy computed tomography concurrent radiotherapy orthotopic model recombinant human endostatin definitive radiation therapy chemoradiation therapy neovascularization drug trials clinical mycology cancer growth cancer risk tumor growth definitive radiotherapy advanced pancreatic cancer survival outcomes non-small-cell lung cancer lung adenocarcinoma endothelial dysfunction combined modality treatment biomedical modeling unresectable nsclc severe radiation pneumonitis cytokines apoptosis vascular disease gynecologic oncology pathology carcinogenesis cancer discovery medical history breast cancer medical physics surgery translational research microsurgery surgical pathology oral radiology jama oncology gynecologic cancers anatomical pathology oral pathology medical imaging medical education cancer letter tumor microenvironment metastasis sarcoma brain tumor research surgical education mesothelioma science and technology studies neuro-oncology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Outcomes and Toxicity Following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. Clinical Lung Cancer (2025)

more definitive courseslung cancermedicineradiation therapythoracic radiation therapyoncologyradiation oncologyradiationcancer carethoracic oncologyclinical radiation oncology

Phase II Trial of Autologous Lymphocyte Infusions After Radiotherapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients With Solid Tumor Malignancies. International Journal of Radiation Oncology*Biology*Physics (2025)

cellular therapyphase ii trialoncologyradiation oncologycell therapysolid tumor malignanciesradiationmalignant blood disorderslymphoid neoplasiaimmunologyautologous lymphocyte infusionscell transplantation

S915 Endoscopic Ultrasound-Guided Injection of Nbtxr3 Activated by Radiotherapy With Concurrent Chemotherapy for Esophageal Adenocarcinoma: Interim Analysis of Feasibility and Safety. The American Journal of Gastroenterology (2025)

ultrasoundesophageal adenocarcinomacancer imagingradiation therapycancer researchradiation oncologyoncologysurgerygastrointestinal oncologyesophageal cancerinterim analysisnbtxr3 activatedradiationradiologygastrointestinal endoscopy

1915P Phase I Trial of Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma. Annals of Oncology (2024)

lung cancercancer immunotherapyradiation therapyoncologyradiation oncologyadjuvant pembrolizumabclinical radiation oncologythoracic oncologymesotheliomacancer treatmentradiologyjama oncologybronchial neoplasm

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral. Journal of the National Comprehensive Cancer Network (2024)

surgical oncologyradiation therapydefinitive radiotherapyoncologyradiation oncologythyroidthyroid diseaseneuro-oncologyoligoprogressive thyroid cancersystemic therapy deferral

Knowledge-Based Planning for Fully Automated Radiation Therapy Treatment Planning of 10 Different Cancer Sites. Radiotherapy and Oncology (2024)

Christine V ChungMeena S KhanAdenike OlanrewajuMary PhamQuyen T NguyenTina PatelPrajnan DasMichael S O'ReillyValerie K ReedAnuja JhingranHannah SimondsEthan B LudmirKaren E HoffmanKomeela NaidooJeannette ParkesAjay AggarwalLauren L MayoShalin J ShahChad TangBeth M BeadleJulie WetterGary WalkerSimon HughesVinod MullasseryStephen SkettChristopher ThomasLifei ZhangSon NguyenRaymond P MummeRaphael J DouglasHana BaroudiLaurence E Court

radiation therapyoncologyradiation oncologydifferent cancer sitesradiationcancer treatmenttreatment planningradiation therapy planningknowledge-based planning

P3.06D.03 Prognostic and Predictive Ctdna Signature for Patients on Targeted Therapy for Metastatic Nsclc: A Pathway-Based Approach. Journal of Thoracic Oncology (2024)

metastasislung cancermolecular diagnosticscancer genomicsmetastatic nsclconcologyradiation oncologymolecular cancerthoracic oncologycancer treatmenttargeted therapyprognostic biomarkerspredictive ctdna signaturecancer geneticspathology

Salvage Reirradiation With Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers (2024)

lung cancercancer imagingradiation therapyoncologyradiation oncologyradiationclinical radiation oncologythoracic oncologyproton therapyradiologyproton beam therapysalvage reirradiationnuclear medicine

Survival Outcomes and Toxicity of Adjuvant Immunotherapy After Definitive Concurrent Chemotherapy With Proton Beam Radiation Therapy for Patients With Inoperable Locally Advanced Non-Small Cell Lung Carcinoma. Radiotherapy and Oncology (2024)

lung cancermedicineradiation therapyadjuvant immunotherapyoncologyradiation oncologydefinitive concurrent chemotherapysurvival outcomesradiationimmunotherapythoracic oncologyproton therapynuclear medicine

249P a Retrospective Review of Patients Receiving Trastuzumab Deruxtecan Across Five Centres in Ireland With a Subgroup Analysis of Patients With Cns Involvement Assessing Response in the Cns. ESMO Open (2023)

medicineneuropathologycns involvementsclerodermaneurosurgerya retrospective reviewneuro-oncologyclinical neurologyfacial painneurologysubgroup analysis

1
2
3
4
5
14
10 / page

Michael S O'Reilly, MD

Professor Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Radiation Oncology

Department Of Experimental Radiation Oncology

Department Of Thoracic Radiation Oncology

Department Of Thoracic Surgery

Department Of Thoracic-Head And Neck Med Onc

Division Of Radiation Oncology

The University of Texas MD Anderson Cancer Center

Michael S O'reilly, Md is currently serving as a Breast Radiation Oncology Professor Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael S O'Reilly, MD

The University of Texas MD Anderson Cancer Center

Professor Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Outcomes and Toxicity Following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. Clinical Lung Cancer (2025)

more definitive courseslung cancermedicineradiation therapythoracic radiation therapyoncologyradiation oncologyradiationcancer carethoracic oncologyclinical radiation oncology

1915P Phase I Trial of Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma. Annals of Oncology (2024)

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral. Journal of the National Comprehensive Cancer Network (2024)

surgical oncologyradiation therapydefinitive radiotherapyoncologyradiation oncologythyroidthyroid diseaseneuro-oncologyoligoprogressive thyroid cancersystemic therapy deferral

Knowledge-Based Planning for Fully Automated Radiation Therapy Treatment Planning of 10 Different Cancer Sites. Radiotherapy and Oncology (2024)

radiation therapyoncologyradiation oncologydifferent cancer sitesradiationcancer treatmenttreatment planningradiation therapy planningknowledge-based planning

P3.06D.03 Prognostic and Predictive Ctdna Signature for Patients on Targeted Therapy for Metastatic Nsclc: A Pathway-Based Approach. Journal of Thoracic Oncology (2024)

Salvage Reirradiation With Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers (2024)

medicineneuropathologycns involvementsclerodermaneurosurgerya retrospective reviewneuro-oncologyclinical neurologyfacial painneurologysubgroup analysis

1
2
3
4
5
14
10 / page